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Perivascular epithelioid cell neoplasms (PEComa) are rare mesenchymal tumors that can occur in any
part of the body and have unpredictable pathological behavior. They are usually benign, but may be
malignant. We present a case of malignant PEComa of the pelvic retroperitoneum treated with radical
surgery.
 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Perivascular epithelioid cell neoplasms (PEComas) are deﬁned
by the World Health Organisation Classiﬁcation of Tumors of Soft
Tissue and Bone as mesenchymal tumors composed of perivascular
epithelioid cells with unique histological properties and immuno-
phenotypes.1 Their rarity renders diagnosis difﬁcult, and stan-
dardized treatment protocols are not available as yet.Case presentation
A 70-year-old man presented to the urologist with a 1-month
history of ﬂank pain. No sweating, weight loss or other complaints
were reported. Ultrasonography revealed hydronephrosis of the
right kidney and an ipsilateral solid pelvic mass. Cystoscopy was
unremarkable. Computed tomography (CT) identiﬁed a hypodense
(15e50 Hounsﬁeld units), partially solid and partially cystic tumor,
with moderate contrast uptake (Fig. 1).Perivascular Epitheloid Cell
rea).
Inc. This is an open access article uThe histological examination of a CT-guided biopsy showed
large, polymorphic cells with eosinophilic cytoplasm and nucleoli
with some mitosis. Upon immunohistochemical staining, the cells
were positive for vimentin and EMA, and negative for cytokeratin
(CAM 5.2), AE1/AE3, 7, melan-A, S-100, chromogranin, parvalbu-
min, smooth muscle actin, desmin and CD30. CD138 showed an
active plasmocellular component.
Open surgery was subsequently performed, in which a peri-
ureteral growth without inﬁltrationwas observed. The distal ureter
was resected and re-implanted into the bladder. A complete
resection of the neoplasm with negative margins was achieved.
Routine H&E staining and immunohistochemistry were per-
formed on the formalin-ﬁxed, parafﬁn-embedded tissue section
using a panel of the following antibodies: inhibin, SF1, SMA,
HMB45, desmin, caldesmon, CAM 5.2, CD34, S-100, BCL-2, cyto-
keratin AE1/AE3 and vimentin.Discussion
PEComas represent an unusual family of tumors, characterized
by immunohistochemical evidence of dual myomelanocytic
differentiation.
Renal angiomyolipoma (AML) is the most common PEComa,
with a prevalence of 0.13%. PEComas at other sites, such as softnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Contrast enhanced computer tomography of the pelvis. Transverse plane of the pelvis shows the PEComa in very close contact with the prostate and the posterior wall of
the bladder. The native scan (A) shows a hypodense tumor 15e50 Hounsﬁeld Units with a partially solid and partially cystic conﬁguration. The uptake in the arterial-phase (B) is
uneven. In the venous (C) and delayed-phase (D) a progressive enhancement of the solid part is demonstrated.
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occur mainly in middle aged females (1:7 M:F).2
Immunohistochemical stains play a major role in the diagnosis
of PEComas. These tumors almost always co-express SMA and
HMB45; over 50% of them stain for melan-A (sometimes in the
absence of HMB45), and around 25% are desmin positive. A subset
of cases stain for S-100 protein (allowing possible confusion with
melanoma) and TFE3.2,3
Our case presented a strikingly biphasic appearance. Large
areas of the tumor consisted of sheets of pleomorphic polygonal or
epithelioid cells with pale eosinophilic cytoplasm and large,
irregular vesicular nuclei with variably prominent nucleoli. Scat-
tered mitotic ﬁgures were observed. Elsewhere, the tumor cells
had a more epithelioid morphology with clear cytoplasm and were
arranged in nests (Fig. 2). While stains for inhibin and SF1 wereTable 1
Proposed classiﬁcation of PEComas2
Criteria
Benign <5 cm in diameter
Non-inﬁltrative
Non-high nuclear grade and cellularity





One or both of the following features:
Nuclear pleomorphism/multinucleated giant cells
>5 cm in diameter
Malignant Two or more of the following features:
>5 cm in diameter
Inﬁltrative
High nuclear grade and cellularity
Mitotic rate 1/50 HPF
Necrosis
Vascular invasionnegative, helping to exclude adrenocortical carcinoma, multifocal
positivity for HMB45 and SMA was present (Fig. 2) along with
more diffuse positivity for melan-A. Staining for desmin was
negative.
The differential diagnosis of PEComas is fairly broad, and de-
pends on the morphology (epithelioid vs spindled) and location of
the neoplasm. Above all, PEComas must be distinguished from
conventional melanoma and clear cell sarcoma, but gastrointes-
tinal stromal tumor (GIST) and carcinoma (especially clear cell
carcinoma) may also be confused with epithelioid PEComas.
Smooth muscle neoplasm (with epithelioid and spindled
morphology) is another tumor for which PEComas may be
mistaken.2
Clear criteria for malignancy in PEComas have yet to be
formulated. Folpe et al proposed the categorization of PEComas
into three groups based on tumor diameter, nuclear grade and
cellularity, mitotic rate, necrosis, vascular invasion and inﬁltrative
growth (Table 1).2
According to the above criteria, our patient had a malignant,
inﬁltrative growth, >5 cm in diameter, of high nuclear grade
showing evidence of necrosis, but not of metastasis. The beneﬁts
of chemotherapy or radiation in the treatment of PEComa have not
been established thus far, and what little data is available origi-
nates from small case series. Wagner reported on the clinical
outcomes of three consecutive patients with advanced PEComa
treated with Sirolimus. All three had surgery and subsequently
developed either retroperitoneal or lung metastases. After 1 year
of follow-up from the inception of Sirolimus treatment, the disease
was under control in the two patients who had suffered retro-
peritoneal recurrence. Conversely, control of the tumor was not
achieved in the patient with lung recurrence, who died after
8 months of therapy.4
Based on the available evidence, an adjuvant treatment with
Sirolimus may be considered in our patient in the event of
recurrence.4
Figure 2. Pathological and immunohistochemical analysis. (A) PEComa with epithelioid architecture, the tumor cells have nuclear and eosinophilic cytoplasm with marked
pleomorphism (hematoxylin and eosin staining; magniﬁcation 4  10). (B) Magniﬁcation of a (metaoxylin and eosin magniﬁcation 10  10). (C) Focal positive reaction with anti-
HMB45 of the neoplasm conﬁnating with the bladder. On the top evidence of lamina propria and tunica muscularis * (magniﬁcation 2  10). (D) Magniﬁcation of A (magniﬁcation
10  10). (E) Focal positive reaction with anti-SMA on the left side * with positive intern control of the tunica muscularis on the right side** (magniﬁcation 2  10). (F) Magniﬁcation
of A (magniﬁcation 10  10).
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We removed the tumor surgically. Thus far, in the course of the
subsequent 9 months of follow-up, no signs of recurrence have
been observed. Close clinical surveillance accompanied by radio-
logical imaging is mandatory.
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